Learn more about a Durham NC-based organization working hard to provide a healthy start for local families in need. A young mother stands in the grocery isle contemplating her options. …
Meet Sofia Hornstein, senior and Mechanical Engineering major at Duke University and Shreyas Bhat, Master’s degree candidate in Computer Engineering at Virginia Tech. They’re two of our many talented interns …
Baebies was recently awarded $2.7 million in a Phase IIB SBIR grant from the National Institutes of Health (NIH). This award supports validation, clinical evaluation, and FDA submission of a rapid test panel for near-patient heparin monitoring. This project is a continuation of a long-standing collaboration with Boston Children’s Hospital.
Meet the faces behind Baebies CLIA lab including their daily motivation and favorite superheros. Our team provides second tier targeted next-generation sequencing (tNGS) services to newborn screening programs – because everyone deserves a healthy start.
Baebies announced today that CARB-X has awarded the company up to $11.6 million in non-dilutive funding. This funding will support the development of a near-patient and rapid diagnostic platform for sepsis – specially focused on addressing the unique needs of neonatal and pediatric populations.
While the APHL NBS Symposium 2021 will not take place in person, stay tuned for details on virtual information sharing. Baebies is a sustaining member of APHL.
Innovative digital microfluidic diagnostic platform FINDER is named a finalist for the 2021 Medical Design Excellence Awards (MDEA) – recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.
This 12-minute presentation was given by Vamsee Pamula, Co-Founder & President of Baebies, in an online forum hosted by Medical Lab Observer (MLO). Watch the webinar to learn how digital microfluidics enables ultra-rapid thermocycling for PCR.
Baebies has delivered 10 million tests to newborn screening labs around the world since the company was founded. This milestone translates to 10 million chances to provide a healthy start. Learn more about Baebies mission and growth.
According to the CDC, the “gold standard” for SARS-CoV-2 testing is reverse transcription polymerase chain reaction (or RT-PCR). Digital microfluidics enables ultra-rapid PCR results by utilizing low droplet volume with built-in heaters and sensors on cartridge.